CNS Pharmaceuticals Inc.
(CNSP)
undefined
undefined%
At close: undefined
0.10
2.31%
Pre-market Dec 16, 2024, 05:50 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 548.72K | 10.06M | 5.00M | 14.04M | 7.24M | 282.74K | 110.54K |
Short-Term Investments | - | - | - | - | - | - | - |
Long-Term Investments | - | - | - | - | - | - | - |
Other Long-Term Assets | 104.75K | 482.81K | 1.26M | 334.14K | -0.00 | 95.20K | - |
Receivables | - | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - | - |
Other Current Assets | 1.04M | 5.02M | 2.47M | 1.46M | 652.62K | 305.40K | 51.65K |
Total Current Assets | 1.59M | 12.56M | 7.48M | 15.50M | 7.89M | 588.13K | 162.19K |
Property-Plant & Equipment | 4.93K | 5.66K | 16.11K | 23.43K | 18.16K | - | - |
Goodwill & Intangibles | - | - | - | - | - | - | - |
Total Long-Term Assets | 109.68K | 488.47K | 1.28M | 357.57K | 18.16K | 95.20K | - |
Total Assets | 1.70M | 13.05M | 8.76M | 15.85M | 7.91M | 683.33K | 162.19K |
Account Payables | 5.83M | 3.68M | 1.98M | 946.33K | 289.50K | 128.87K | 57.50K |
Deferred Revenue | - | - | - | - | - | 23.60K | - |
Short-Term Debt | 300.81K | 409.97K | 387.79K | 439.29K | - | 316.92K | 121.83K |
Other Current Liabilities | - | 828.39K | 224.95K | 519.80K | 21.50K | 786.85K | 41.40K |
Total Current Liabilities | 6.13M | 4.92M | 2.14M | 1.91M | 311.00K | 1.23M | 220.73K |
Long-Term Debt | - | - | - | - | - | - | - |
Other Long-Term Liabilities | - | - | - | - | - | - | - |
Total Long-Term Liabilities | - | 4.09M | - | - | - | 445.78K | 179.32K |
Total Liabilities | 6.13M | 4.92M | 2.14M | 1.91M | 311.00K | 1.23M | 220.73K |
Total Debt | 300.81K | 409.97K | 387.79K | 439.29K | - | 316.92K | 121.83K |
Common Stock | 6.21K | 1.62K | 27.93K | 23.86K | 16.45K | 12.70K | 10.27K |
Retained Earnings | -69.57M | -50.72M | -34.98M | -20.95M | -11.49M | -7.61M | -219.36K |
Comprehensive Income | - | - | - | -0.00 | -0.00 | - | - |
Shareholders Equity | -4.43M | 8.13M | 6.62M | 13.95M | 7.60M | -549.30K | -58.53K |
Total Investments | - | - | - | - | - | - | - |